Phase I-II Study of Intratumoral Urelumab Combined With Nivolumab in Patients With Solid Tumors

NCT03792724 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Neoplasms

Interventions

DRUG: Urelumab + Nivolumab

Sponsor

Clinica Universidad de Navarra, Universidad de Navarra